CathOlic Medical Center percutAneous Coronary inTervention Registry (COACT)

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2010 by The Catholic University of Korea
Sponsor:
Collaborators:
Seoul St. Mary's Hospital
St.Paul's Hospital, Korea
Incheon St.Mary's Hospital
St.Vincent's Hospital of Korea
Information provided by:
The Catholic University of Korea
ClinicalTrials.gov Identifier:
NCT01239914
First received: November 12, 2010
Last updated: August 24, 2012
Last verified: July 2010

November 12, 2010
August 24, 2012
January 2005
December 2014   (final data collection date for primary outcome measure)
  • All causes mortality [ Time Frame: 6month, each year ] [ Designated as safety issue: Yes ]
  • Cardiac death [ Time Frame: 6 month, each year ] [ Designated as safety issue: Yes ]
  • Myocardial infarction [ Time Frame: 6 month, each year ] [ Designated as safety issue: Yes ]
  • target lesion revascularization [ Time Frame: 6 month, each year ] [ Designated as safety issue: Yes ]
  • target vessel revascularization [ Time Frame: 6 month, each year ] [ Designated as safety issue: Yes ]
Same as current
Complete list of historical versions of study NCT01239914 on ClinicalTrials.gov Archive Site
  • non target vessel revascularization [ Time Frame: 6 month, each year ] [ Designated as safety issue: Yes ]
  • Stent thrombosis [ Time Frame: 6 month, each year ] [ Designated as safety issue: Yes ]
  • Serum databank for evaluation of biomarkers outcomes [ Time Frame: 6 month, each year ] [ Designated as safety issue: Yes ]
  • Pharmacogenetic and cardiovascular genetic studies associated to clinical outcomes [ Time Frame: 6 month, each year ] [ Designated as safety issue: Yes ]
Same as current
Not Provided
Not Provided
 
CathOlic Medical Center percutAneous Coronary inTervention Registry (COACT)
CathOlic Medical Center percutAneous Coronary inTervention Registry (COACT)

COACT registry is a multicenter registry of consecutive patients undergoing coronary stent implantation at 8 centers in the Catholic University of Korea to evaluate the real world management of patients with coronary artery disease and to assess their in-hospital, medium and long-term outcomes.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Retrospective
Not Provided
Retention:   Samples With DNA
Description:

Whole blood, serum and DNA

Non-Probability Sample

all comers who admitted cardiovascular center for coronary stent implantation

  • Drug Eluting Stent
  • Coronary Artery Disease
  • Polymorphism
  • Cholesterol
  • Biomarker
Not Provided
Not Provided
Kim HS, Chang K, Koh YS, Park MW, Choi YS, Park CS, Oh M, Kim EY, Shon JH, Shin JG, Seung KB. CYP2C19 poor metabolizer is associated with clinical outcome of clopidogrel therapy in acute myocardial infarction but not stable angina. Circ Cardiovasc Genet. 2013 Oct;6(5):514-21. doi: 10.1161/CIRCGENETICS.113.000109. Epub 2013 Sep 9.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
11000
December 2014
December 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • all consecutive patients who underwent percutaneous coronary intervention
  • written informed consent for the DNA and serum databank

Exclusion Criteria:

  • patients who did not agreed to participate
Both
18 Years and older
No
Contact: Ki-Bae Seung, M.D., PhD +82-2-2258-1142 kbseung@catholic.ac.kr
Korea, Republic of
 
NCT01239914
COACT
Yes
Ki-Bae Seung, Seoul St.Mary's Hospital
The Catholic University of Korea
  • Seoul St. Mary's Hospital
  • St.Paul's Hospital, Korea
  • Incheon St.Mary's Hospital
  • St.Vincent's Hospital of Korea
Study Chair: Ki-Bae Seung, M.D.,PhD Seoul St. Mary's Hospital
The Catholic University of Korea
July 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP